Evidence map›Paper›PMID 41069484›Full record

ArticleTherapeutic advances in drug safety2025

Knowledge, attitude, and practice regarding pharmacovigilance among hospital pharmacists in China.

Yinchu Cheng, Tingting Qiu, Xiaole Zhang, Qi Zhou, Xiaojuan Li, Ailing Song, Qunhong Shen, Fang Liu

Abstract read
In one paragraph

Article in Therapeutic advances in drug safety, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yinchu ChengDepartment of Pharmacy, Peking University Third Hospital, Beijing, China.ORCID https://orcid.org/0000-0001-6084-0384
Tingting QiuDepartment of Pharmacy, Peking University Third Hospital, Beijing, China.ORCID https://orcid.org/0000-0001-7192-4778
Xiaole ZhangThe Partnership for Safe Medicines Beijing Foundation, Beijing, China.
Qi ZhouSchool of Public Policy and Management, Tsinghua University, Beijing, China.
Xiaojuan LiDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Ailing SongShanghai MediTrust Health Technology Group Co., Ltd, Shanghai, China.
Qunhong ShenSchool of Public Policy and Management, Tsinghua University, Beijing 100084, China.
Fang LiuDepartment of Pharmacy, Peking University Third Hospital, No. 49 North Garden Road, Haidian District, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pharmacovigilance is essential for ensuring patient safety, and hospital pharmacists play a key role in this system. However, their knowledge, attitudes, and practices (KAP) remain understudied in China. Objectives: To evaluate the KAP of hospital pharmacists toward pharmacovigilance in China. Design: Nationwide, cross-sectional study. Methods: This study evaluated the KAP of 9724 hospital pharmacists from 2145 hospitals across all 31 provinces of mainland China using a structured questionnaire and a multi-stage sampling approach. Descriptive statistics were used to summarize the KAP of the participants, and multivariable logistic regression was applied to explore the influencing factors of high KAP performance. Results: The proportions of respondents achieving high performance (score ⩾4 out of a maximum of 5) in knowledge, attitudes, and practices were 22.2%, 44.2%, and 68.0%, respectively, with significant correlations between these dimensions ( Conclusion: Our study reveals a significant scope for enhancement in the KAP of hospital pharmacists pertaining to pharmacovigilance in China. Specifically, there is a critical need to improve the understanding of pharmacovigilance's scope and responsibilities, and fostering stronger collaborative efforts between medical institutions and MAH is imperative, particularly within targeted pharmacist groups.

Indexed as

attitudedrug safetyknowledgepharmacistpharmacovigilancepractice

Identifiers

PMID41069484
PMCPMC12504845

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.